GeneLink, Inc. (GNLKQ) Research

GeneLink, Inc. specializes in delivering 12-gene DNA profiling services. Beyond genetic analyses, the company also provides clients with bespoke nutritional supplements tailored to individual health needs. Additionally, the firm crafts a comprehensive collection of dermatological products. Established in 1994, GeneLink, Inc. maintains its headquarters in Orlando, Florida.

Market snapshot

Symbol
GNLKQ
Price
$0.00
Day change
0.00%
Market cap
$10.6K
P/E ratio
-0.00x
52-week range
0.00001-0.00004
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • Baseline Productions, Inc. (BSSP)
  • CNBX Pharmaceuticals Inc. (CNBX)
  • Endonovo Therapeutics, Inc. (ENDV)
  • Filament Health Corp. (FLHLF)
  • G Medical Innovations Holdings Ltd (GMVDF)
  • Itoco Inc. (ITMC)
  • Microart Inc. (MCRT)
  • Nutranomics, Inc. (NNRX)

Open GeneLink, Inc. (GNLKQ) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.